T1	Participants 159 178	duodenal ulceration
T2	Participants 224 435	multi-clinic study comparing the therapeutic efficacy and degree of oral staining of new colloidal bismuth subcitrate (CBS) coated tablets over 4 weeks of treatment in patients suffering from duodenal ulceration
T3	Participants 479 556	9 clinics in the Netherlands, Belgium, Ireland, the United Kingdom, and Italy
T4	Participants 575 667	94 patients treated with CBS coated tablets and 95 patients treated with CBS chewing tablets
